Indoco Remedies Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market Allopurinol Tablets USP 200 mg, a generic version of ZYLOPRIM 200 mg by Casper Pharma LLC.
Allopurinol is commonly prescribed to reduce high levels of uric acid in the blood, particularly in patients undergoing cancer treatment or those with kidney stones.
The approved product will be manufactured at Indoco’s facility located in L-14, Verna Industrial Area, Verna, Goa – 403722, India.
Commenting on the milestone, Ms. Aditi Panandikar, Managing Director, said, “This approval not only underscores Indoco’s ability to deliver high-quality products but also strengthens our growth trajectory in a key market like the US.”